HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kazuya Kuraoka Selected Research

Rhabdomyosarcoma

1/2020Primary cardiac rhabdomyosarcoma successfully treated with eribulin: a case report.
6/2017Primary cardiac rhabdomyosarcoma developed after receiving radiotherapy for left breast cancer 18 years prior.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kazuya Kuraoka Research Topics

Disease

36Neoplasms (Cancer)
04/2024 - 01/2002
10Stomach Neoplasms (Stomach Cancer)
10/2023 - 02/2002
9Neoplasm Metastasis (Metastasis)
04/2023 - 02/2002
9Breast Neoplasms (Breast Cancer)
02/2023 - 11/2003
9Carcinoma (Carcinomatosis)
01/2023 - 02/2002
8Adenocarcinoma
04/2024 - 02/2002
5Colorectal Neoplasms (Colorectal Cancer)
06/2021 - 11/2017
4Renal Cell Carcinoma (Grawitz Tumor)
05/2024 - 04/2020
4Carcinogenesis
10/2005 - 06/2002
3Lymphatic Metastasis
02/2023 - 04/2004
3Colonic Neoplasms (Colon Cancer)
01/2023 - 11/2017
2Brain Neoplasms (Brain Tumor)
04/2023 - 01/2023
2Infections
03/2023 - 04/2009
2Disease Progression
02/2023 - 02/2002
2Hematoma
01/2022 - 12/2020
2Cavernous Hemangioma (Cavernous Angioma)
01/2022 - 12/2020
2Hyperplasia
01/2022 - 12/2020
2Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
04/2021 - 12/2018
2Rupture
04/2021 - 12/2018
2Rhabdomyosarcoma
01/2020 - 06/2017
1Liver Neoplasms (Liver Cancer)
04/2024
1Rheumatoid Arthritis
01/2024
1Spontaneous Remission
01/2024
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2024
1Noninfiltrating Intraductal Carcinoma (DCIS)
12/2023
1Hodgkin Disease (Hodgkin's Disease)
12/2023
1Anaplastic Thyroid Carcinoma
04/2023
1Head and Neck Neoplasms (Head and Neck Cancer)
03/2023
1Liver Cirrhosis (Hepatic Cirrhosis)
03/2023
1Osteosarcoma (Osteogenic Sarcoma)
02/2023
1Cholangiocarcinoma
02/2023
1Glioblastoma (Glioblastoma Multiforme)
01/2023
1Primitive Neuroectodermal Tumors (PNET)
01/2023
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2023
1Pancreatic Neoplasms (Pancreatic Cancer)
11/2022
1Respiratory Insufficiency (Respiratory Failure)
01/2022
1Colitis
08/2021
1Paresthesia (Dysesthesia)
08/2021
1Fasciculation (Fasciculations)
08/2021
1Polyradiculoneuropathy (Polyradiculoneuritis)
08/2021
1Peripheral Nervous System Diseases (PNS Diseases)
08/2021
1Muscle Weakness
08/2021

Drug/Important Bio-Agent (IBA)

10Proteins (Proteins, Gene)FDA Link
12/2023 - 02/2002
4RNA (Ribonucleic Acid)IBA
10/2023 - 02/2002
4antineoplaston A10 (A 10)IBA
04/2022 - 10/2020
4Biomarkers (Surrogate Marker)IBA
04/2022 - 05/2004
4AnnexinsIBA
04/2022 - 10/2020
4Messenger RNA (mRNA)IBA
01/2022 - 02/2002
3KinesinsIBA
12/2023 - 01/2023
3MucinsIBA
10/2023 - 08/2005
3Keratins (Keratin)IBA
05/2022 - 12/2015
3Progesterone Receptors (Progesterone Receptor)IBA
01/2022 - 03/2012
3human ERBB2 proteinIBA
01/2022 - 01/2018
3Sunitinib (Sutent)FDA Link
10/2021 - 04/2020
3Imatinib Mesylate (Gleevec)FDA Link
04/2021 - 12/2018
2Serine Proteases (Serine Protease)IBA
04/2024 - 01/2022
2GemcitabineFDA Link
03/2023 - 02/2023
2Cisplatin (Platino)FDA LinkGeneric
02/2023 - 02/2023
2Immune Checkpoint InhibitorsIBA
01/2023 - 01/2021
2VimentinIBA
05/2022 - 12/2015
2CalponinsIBA
05/2022 - 01/2021
2Nucleic AcidsIBA
01/2022 - 03/2018
2Capsules (Microcapsules)IBA
01/2022 - 12/2020
2AntibodiesIBA
08/2021 - 01/2020
2pembrolizumabIBA
08/2021 - 07/2021
2DNA (Deoxyribonucleic Acid)IBA
03/2021 - 01/2002
2Hormones (Hormone)IBA
10/2019 - 01/2018
2Estrogen ReceptorsIBA
10/2019 - 03/2012
2A-factor (Streptomyces)IBA
12/2018 - 06/2018
2Type II DNA Topoisomerases (Topoisomerase II)IBA
06/2018 - 03/2012
2NucleotidesIBA
08/2005 - 11/2003
2alpha2 Subunit Collagen Type IIBA
05/2004 - 04/2004
1Somatostatin Receptors (Somatostatin Receptor)IBA
05/2024
1somatostatin receptor 2IBA
05/2024
1Small Interfering RNA (siRNA)IBA
04/2024
1Antirheumatic Agents (DMARD)IBA
01/2024
1tocilizumab (atlizumab)FDA Link
01/2024
1GTPase-Activating Proteins (GTPase-Activating Protein)IBA
12/2023
1Gastric MucinsIBA
10/2023
1lenvatinibIBA
04/2023
1Tyrosine Kinase InhibitorsIBA
04/2023
1Doxorubicin (Adriamycin)FDA LinkGeneric
02/2023
1Bevacizumab (Avastin)FDA Link
01/2023
1Temozolomide (Temodar)FDA LinkGeneric
01/2023
1Keratin-19 (Keratin 19)IBA
01/2022
1AutoantibodiesIBA
08/2021
1Rheumatoid FactorIBA
08/2021
1GangliosidesIBA
08/2021
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
08/2021
1B7-H1 AntigenIBA
07/2021

Therapy/Procedure

9Therapeutics
01/2024 - 05/2004
7Drug Therapy (Chemotherapy)
12/2023 - 07/2016
3Adjuvant Chemotherapy
04/2024 - 04/2021
2Mastectomy (Mammectomy)
12/2023 - 06/2017
2Lymph Node Excision (Lymph Node Dissection)
02/2023 - 02/2013
2Immunotherapy
07/2021 - 01/2021
2Aftercare (After-Treatment)
03/2019 - 11/2017
2Radiotherapy
06/2017 - 07/2016
2Precision Medicine
05/2004 - 06/2002
1Chemoradiotherapy
01/2023